Centralization and Equitable Care in Rare Urogenital Malignancies: The Case for Penile Cancer

Jakob K. Jakobsen*, Curtis A. Pettaway, Benjamin Ayres

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisReviewForskningpeer review

Abstract

Centralization of specialized care for rare cancers can improve patient outcomes. Inguinal lymph node evaluation is the most important clinical aspect of penile cancer care and is often neglected in a decentralized setting. Centralization of care may reduce system delays, improve guideline adherence, provide access to a wider team of specialists, and improve prognosis, albeit with some inconveniences for patients. Patient summary: We reviewed evidence for the centralization of care for penile cancer. Patients may have to travel greater distances to receive specialized care in expert centers. However, centralization means that rare cancers can be treated by more experienced surgeons, which can yield better outcomes in terms of survival and penis-preserving or reconstruction surgery.

OriginalsprogEngelsk
TidsskriftEuropean Urology Focus
Vol/bind7
Nummer5
Sider (fra-til)924-928
Antal sider5
DOI
StatusUdgivet - sep. 2021

Fingeraftryk

Dyk ned i forskningsemnerne om 'Centralization and Equitable Care in Rare Urogenital Malignancies: The Case for Penile Cancer'. Sammen danner de et unikt fingeraftryk.

Citationsformater